Strategic Financial Services, Inc, Merck & Co., Inc. Transaction History

Strategic Financial Services, Inc,

$1.68 Billion
Q3 2024

A detailed history of Strategic Financial Services, Inc, transactions in Merck & Co., Inc. stock. As of the latest transaction made, Strategic Financial Services, Inc, holds 24,298 shares of MRK stock, worth $2.41 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

24,298

Previous 24,337 0.16%

Holding current value

$2.41 Million

Previous $3.01 Million 8.4%

% of portfolio

0.16%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $4,334 - $5,029	-39 Reduced 0.16%	24,298 $2.76 Million
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $151,655 - $162,876	1,225 Added 5.3%	24,337 $3.01 Million
Q1 2024 May 07, 2024	SELL	$113.24 - $131.95 $72,473 - $84,448	-640 Reduced 2.69%	23,112 $3.05 Million
Q4 2023 Feb 08, 2024	SELL	$100.18 - $109.02 $34,061 - $37,066	-340 Reduced 1.41%	23,752 $2.59 Million
Q3 2023 Nov 06, 2023	SELL	$102.95 - $114.33 $36,650 - $40,701	-356 Reduced 1.46%	24,092 $2.48 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $4,127 - $4,498	-38 Reduced 0.16%	24,448 $2.82 Million
Q1 2023 May 12, 2023	SELL	$102.94 - $114.86 $196,615 - $219,382	-1,910 Reduced 7.24%	24,486 $2.61 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $269,839 - $345,971	-3,086 Reduced 10.47%	26,396 $2.93 Million
Q3 2022 Nov 09, 2022	SELL	$84.53 - $94.96 $115,383 - $129,620	-1,365 Reduced 4.43%	29,482 $2.54 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $232,519 - $263,572	-2,785 Reduced 8.28%	30,847 $2.81 Million
Q1 2022 Apr 26, 2022	SELL	$73.51 - $82.4 $71,010 - $79,598	-966 Reduced 2.79%	33,632 $2.76 Million
Q4 2021 Feb 15, 2022	SELL	$72.28 - $90.54 $42,645 - $53,418	-590 Reduced 1.68%	34,598 $2.65 Million
Q3 2021 Nov 15, 2021	SELL	$71.68 - $78.83 $66,734 - $73,390	-931 Reduced 2.58%	35,188 $2.64 Million
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $36,209 - $40,051	-515 Reduced 1.41%	36,119 $2.81 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $275,922 - $325,007	-4,007 Reduced 9.86%	36,634 $2.82 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $51,602 - $57,268	-719 Reduced 1.74%	40,641 $3.32 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $126,601 - $143,503	-1,730 Reduced 4.01%	41,360 $3.43 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $1.42 Million - $1.61 Million	-20,123 Reduced 31.83%	43,090 $3.33 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $670,982 - $930,013	-10,590 Reduced 14.35%	63,213 $4.86 Million
Q4 2019 Feb 13, 2020	SELL	$77.58 - $87.54 $1.13 Million - $1.27 Million	-14,543 Reduced 16.46%	73,803 $6.71 Million
Q3 2019 Nov 14, 2019	SELL	$76.08 - $82.93 $156,344 - $170,421	-2,055 Reduced 2.27%	88,346 $7.44 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $108,601 - $126,872	-1,555 Reduced 1.69%	90,401 $7.58 Million
Q1 2019 Apr 23, 2019	SELL	$69.58 - $79.36 $127,957 - $145,943	-1,839 Reduced 1.96%	91,956 $7.65 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $44,363 - $51,482	-680 Reduced 0.72%	93,795 $7.17 Million
Q3 2018 Oct 25, 2018	SELL	$57.69 - $67.84 $462,096 - $543,398	-8,010 Reduced 7.82%	94,475 $6.7 Million
Q2 2018 Aug 06, 2018	BUY	$50.83 - $59.72 $50,931 - $59,839	1,002 Added 0.99%	102,485 $6.22 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $1.56 Million - $1.81 Million	30,623 Added 43.22%	101,483 $5.53 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $32,262 - $38,525	625 Added 0.89%	70,860 $3.99 Million
Q3 2017 Nov 06, 2017	SELL	$58.67 - $63.13 $2,992 - $3,219	-51 Reduced 0.07%	70,235 $4.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	70,286	70,286 $4.51 Million

Others Institutions Holding MRK

# of Institutions

3,829

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.

Account

Strategic Financial Services, Inc, Merck & Co., Inc. Transaction History